Analysts are maintaining bullish end-2022 targets, even as the Omicron variant is the latest hurdle to the market’s eventful recovery journey. Meanwhile, will the much-heralded Spac framework carry the IPO momentum forward?

Singapore may have seen multiple months of lockdowns and fewer IPOs in 2021, but market optimism is in no short supply, even amid fears of the new Omicron Covid-19 variant, first identified in late-November.

This time last year, analysts were expecting the Straits Times Index (STI) to recover from the lows of 2,200 during the “circuit breaker”.

To continue reading,

Sign in to access this Premium article.

Subscription entitlements:

Less than $9 per month
3 Simultaneous logins across all devices
Unlimited access to latest and premium articles
Bonus unlimited access to online articles and virtual newspaper on The Edge Malaysia (single login)

Related Stories

Stay updated with Singapore corporate news stories for FREE

Follow our Telegram | Facebook